BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

737 related articles for article (PubMed ID: 12010662)

  • 21. High intracellular content of cyclin-dependent kinase inhibitor p27(Kip1) in early- and intermediate stage B-cell chronic lymphocytic leukemia lymphocytes predicts rapid progression of the disease.
    Wolowiec D; Wojtowicz M; Ciszak L; Kosmaczewska A; Frydecka I; Potoczek S; Urbaniak-Kujda D; Kapelko-Slowik K; Kuliczkowski K
    Eur J Haematol; 2009 Apr; 82(4):260-6. PubMed ID: 19187271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL).
    Junevik K; Werlenius O; Hasselblom S; Jacobsson S; Nilsson-Ehle H; Andersson PO
    Ann Hematol; 2007 Feb; 86(2):89-94. PubMed ID: 17043777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow T-cell subsets in patients with monoclonal gammopathies: correlation with clinical stage and disease status.
    Corso A; Castelli G; Pagnucco G; Lazzarino M; Bellio L; Klersy C; Bernasconi C
    Haematologica; 1997; 82(1):43-6. PubMed ID: 9107081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccines.
    Gitelson E; Hammond C; Mena J; Lorenzo M; Buckstein R; Berinstein NL; Imrie K; Spaner DE
    Clin Cancer Res; 2003 May; 9(5):1656-65. PubMed ID: 12738718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.
    Molica S; Tucci L; Levato D; Docimo C
    Haematologica; 1997; 82(3):286-90. PubMed ID: 9234573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
    Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
    Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease-related anemia in chronic lymphocytic leukemia is not due to intrinsic defects of erythroid precursors: a possible pathogenetic role for tumor necrosis factor-alpha.
    Tsopra OA; Ziros PG; Lagadinou ED; Symeonidis A; Kouraklis-Symeonidis A; Thanopoulou E; Angelopoulou MK; Vassilakopoulos TP; Pangalis GA; Zoumbos NC
    Acta Haematol; 2009; 121(4):187-95. PubMed ID: 19468203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia.
    Serrano D; Monteiro J; Allen SL; Kolitz J; Schulman P; Lichtman SM; Buchbinder A; Vinciguerra VP; Chiorazzi N; Gregersen PK
    J Immunol; 1997 Feb; 158(3):1482-9. PubMed ID: 9013995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
    Büssing A; Stein GM; Stumpf C; Schietzel M
    Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis.
    Nagy B; Ferrer A; Larramendy ML; Galimberti S; Aalto Y; Casas S; Vilpo J; Ruutu T; Vettenranta K; Franssila K; Knuutila S
    Haematologica; 2003 Jun; 88(6):654-8. PubMed ID: 12801841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis.
    Prabhu Anand S; Selvaraj P; Narayanan PR
    Cytokine; 2009 Feb; 45(2):105-10. PubMed ID: 19091593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL.
    Hami LS; Green C; Leshinsky N; Markham E; Miller K; Craig S
    Cytotherapy; 2004; 6(6):554-62. PubMed ID: 15764021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
    Ye Q; Wang ZH; Qin SK
    Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of tumour necrosis factor and alpha interferon on chronic B cell malignancies.
    Bianchi AC; Heslop HE; Drexler HG; Cordingley FT; Turner M; De Mel WC; Hoffbrand AV; Brenner MK
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):317-9. PubMed ID: 3265501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human-->mouse radiation chimera.
    Shimoni A; Marcus H; Dekel B; Shkarchi R; Arditti F; Shvidel L; Shtalrid M; Bucher W; Canaan A; Ergas D; Berrebi A; Reisner Y
    Cancer Res; 1999 Dec; 59(23):5968-74. PubMed ID: 10606243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.